On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
MondayOct 03, 2022 10:45 am

HeartBeam Inc. (NASDAQ: BEAT) Receives US Patent for Exclusive ECG Patch Monitor Designed to Detect Heart Issues

The USPTO issued a patent for BEAT’s 12-lead electrocardiogram (“ECG”) patch monitor for detection of ACS and cardiac arrhythmia HeartBeam has developed the only 3D-vector ECG platform for heart-attack detection anytime, anywhere BEAT’s patch technology could have a disruptive effect on the ECG patch market with its ischemia detection capability News about heart attacks and other life-threatening cardiovascular issues is alarming. Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States (https://ibn.fm/FN4BR), and recent reports suggest that COVID-19 may cause heart problems (https://ibn.fm/7QAky) and that the incidence of heart…

Continue Reading

MondayOct 03, 2022 10:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Focusing on Multiple Mainstream Applications of Its Disruptive Patented DehydraTECH(TM) Technology

Lexaria is the drug delivery platform innovator behind the disruptive, patented DehydraTECH(TM) technology DehydraTECH is designed to enhance the performance of fat-soluble active pharmaceutical ingredients (“APIs”), molecules, and drugs by increasing their bioavailability Through animal and human studies, Lexaria has shown that DehydraTECH increases the bioavailability of antiviral drugs, CBD, oral nicotine and more The company is focusing on multiple mainstream applications of its technology that rerrcould address serious unmet patient needs Lexaria is currently keen on developing a potential treatment for hypertension  Last summer, drug delivery platform innovator Lexaria Bioscience (NASDAQ: LEXX) announced a review of its successful 2021…

Continue Reading

MondayOct 03, 2022 9:20 am

Business Booming for Golden Matrix Group Inc. (NASDAQ: GMGI) as Online Gambling Continues Growth in Popularity

Data Bridge Market Research forecasts a 13.7% CAGR for the casino online gambling market to reach $144.74 billion in 2028 Golden Matrix Group is demonstrating growth in both its B2B and B2C businesses, as it prepares to enter the Mexican markets GMGI revenue for the first nine months of fiscal 2022 was $26.46 million, up 237% from a year earlier, while the company notched its 16th consecutive profitable quarter For decades, there was little substantial innovation in the gambling industry and then along came the miracle of the internet and changed everything with the emergence on online gaming. Still, most…

Continue Reading

FridaySep 30, 2022 11:15 am

Reklaim Ltd. (TSX.V: MYID) (OTCQB: MYIDF) the Premier Partner Amid Winds of Change to Protect Consumer Data

California’s Consumer Privacy Act, Privacy Rights Act, and Europe’s General Data Protection Regulation represent a changing data market Reklaim is a leader in compliant data with a comprehensive platform that allows consumers to re-take control of their data and be compensated should they decide, it can be bought and sold Reklaim’s revenue jumped 277% year-over-year to $645,008 in Q2 as the company grows organically and explores accretive M&A opportunities In years gone by, not long ago, companies were quietly hoarding as much data as possible from consumers, then promptly selling it for the maximum amount with little to no concern…

Continue Reading

FridaySep 30, 2022 10:30 am

Flora Growth Corp. (NASDAQ: FLGC) Strategic Acquisitions, Expanding Cannabis Exports Give Significant Boost to Company’s Revenue Streams

Flora Growth is a global cannabis cultivator, product builder, and supplier, experiencing continued growth thanks to strategic acquisitions and an expanding supply chain for marketing its brands in various countries Flora announced its most recent acquisition in September — a deal to acquire the assets of the No Cap Hemp Co. brand in exchange for payment of 10 percent of the No Cap brand revenues up to a maximum of $2 million  The deal grants Flora an immediate revenue stream free of closing cost considerations Flora has seen revenues skyrocket over the past year, with a 604 percent YOY increase…

Continue Reading

FridaySep 30, 2022 9:45 am

Sugarmade Inc. (SGMD) Makes Strategic Advancements in Plan to Grow Presence in California Cannabis Space

SGMD inks MSA with California cannabis micro license holder Agreement “lays a foundation for a significantly expanded manufacturing and distribution infrastructure,” says CEO Key partnerships are essential pieces of Sugarmade’s focus on California cannabis space With the recent signing of a management services agreement (“MSA”) (https://ibn.fm/2KYof), Sugarmade (OTC: SGMD) is making key progress toward the goal of strengthening its position in the California cannabis space. SGMD signed the MSA through its subsidiary, SugarRush, which entered into the agreement with Canndis Inc., a California cannabis micro license holder. Canndis holds a license that covers delivery, manufacturing, distribution and cultivation rights, and…

Continue Reading

FridaySep 30, 2022 9:00 am

Correlate Infrastructure Partners Inc. (CIPI) – A Company with the Discipline of a Large Publicly Traded Corporation and the Innovative Mindset of a Start-up

Todd Michaels, Correlate’s President and CEO, shared some insights into the company’s operations, how it came to be, and its plan for the future. He also shared his journey into the clean energy space He emphasized that the company is committed to helping corporations and companies to generate clean energy on-site and set up better technology that guarantees an instant increase in NOI Todd mentioned that Correlate looks to make it increasingly simple for people to find the company and take advantage of its offerings. This, he noted, would be facilitated by the company’s ever-growing team of experts, as well…

Continue Reading

ThursdaySep 29, 2022 11:30 am

NECANN The High Lifestyle Show Comes to Massachusetts

Date: October 7-9, 2022 The first of its kind Cannabis event ‘The High Lifestyle Show’ is finally being held in Massachusetts, on October 7-9, 2022 at the Regency Hotel (Boxborough, MA). The event is organized by NECANN, the leading cannabis event organizer on the East Coast. Being held in a sprawling plush resort hotel, the event will witness a huge gathering of brands, dispensaries, distributors, growers, performers, and consumers, along with exhibitors, vendors, experts, and celebrities, all interacting in a positive socializing and networking environment. While other Canna events revolve around cannabis manufacturing and medication, this NECANN event is a…

Continue Reading

ThursdaySep 29, 2022 10:45 am

GeoSolar Technologies Inc. Poised to benefit as Solar Energy Costs Sink Below Conventional Energy Prices

Renewable energy demand has seen a further increase on the back of rising utility costs Orlando’s Utility Commission recently introduced its third utility price hike of the year and have warned of another potential increase come January 2023 Meanwhile, solar energy prices have now fallen below those of conventional, fossil-fuel generated energy  GeoSolar Technologies proprietary home solution provides homeowners with a mix of lower utility costs and energy independence Speaking at the United Nation’s Climate Change Conference (COP26) last year, Richa Sharma, leader of the Indian delegation stated “The meagre carbon budget is first and foremost the right and entitlement…

Continue Reading

ThursdaySep 29, 2022 10:00 am

Lexaria Bioscience Corp. (NASDAQ: LEXX) Addressing Hypertensive Patients’ Concerns with DehydraTECH-CBD

Lexaria is a global innovator in drug delivery platforms whose lead technology is DehydraTECH(TM) Studies have shown that DehydraTECH increases the intestinal bioabsorption of bioactive compounds by as much as 27 times, hence resulting in greater bioavailability; pre-clinical and human studies have demonstrated that DehydraTECH-CBD enables absorption increases of between 100% and 500% The studies have also shown that DehydraTECH-CBD results in a rapid and sustained drop in blood pressure among hypertension patients Lexaria, which believes there is a significant unmet demand for cost-effective hypertensive treatments with few or no side effects, is working toward commercializing DehydraTECH-CBD to satisfy this…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered